Antoine Bennet

Learn More
INTRODUCTION Acromegaly, a chronic disease caused by GH/IGF-I excess, has a major impact on quality of life (QoL). OBJECTIVE To evaluate QoL of acromegalic patients in relation to control status of(More)
CONTEXT The role of somatostatin analogues (SSTa) in the treatment of acromegaly. OBJECTIVE To evaluate the antihormonal and antitumour efficacy of long-term (up to 18 years) primary treatment with(More)